BAHRAIN has approved the emergency use of the oral Covid-19 antiviral, Paxlovid.
The medication, manufactured by Pfizer, has been authorised for individuals aged 18 and above who suffer from mild to moderate symptoms and are at an increased risk of developing severe Covid-19 that may lead to death .
&uuid=(email))